In the first year of his second term, President Donald Trump has focused his attention on foreign policy and made numerous trips abroad – with an eye toward the Nobel Peace Prize. But as he discusses peace deals with foreign leaders, his ratings domestically have fallen. Critics say that he isn’t doing enough to ease American’s economic concerns. So, this week, Trump returned his attention stateside and kicked off his affordability tour in Pennsylvania, while simultaneously branding “affordability” as a democratic “hoax.”

Today on the politics roundtable, we discuss why Trump’s tour signals the administration’s concerns about the politics of affordability, and how some Democrats could use this as a way to gain an edge during the 2026 midterms.

Host Colby Itkowitz speaks with Dan Merica, the co-anchor of our politics newsletter, The Early Brief, and White House Bureau Chief Matt Viser.

Today's episode was produced by Josh Carroll and Thomas Lu. It was mixed by Sean Carter. It was edited by Reena Flores. Thanks also to our Politics editors.

Subscribe to The Washington Post here. Watch this episode on YouTube here.

The U.S. is in the midst of its biggest overhaul yet to childhood vaccinations, and it is already impacting how families are thinking about immunizing their children.

President Donald Trump recently directed a review of the longstanding childhood vaccine schedule. And just last week, an influential vaccine panel recommended dropping the universal birth dose of the hepatitis B vaccine for newborns, even though medical associations said they lacked evidence and data to support the change.

Today on “Post Reports,” national health reporter Lena Sun breaks down the implications of dropping the hepatitis B vaccine at birth, and how, if the change is approved by the Centers for Disease Control and Prevention, it could affect children’s health nationwide. Then, host Martine Powers speaks with Dr. Nola Jean Ernest about how a growing skepticism toward vaccines is affecting her practice and how she is managing to make the case to patients in the Wiregrass region of Alabama that vaccines matter.

Today’s show was produced by Elana Gordon. It was edited by Peter Bresnan and mixed by Sam Bair. Thanks to editor Fenit Nirappil.

Subscribe to The Washington Post here.

The historic movie and television company now known as Warner Bros. Discovery is in high demand. Last week, Netflix announced it would buy some of the company’s most valuable media portfolio for $83 billion. But Paramount Skydance then launched a hostile bid to buy Warner Bros. Discovery mere days later.

Host Martine Powers speaks with media reporter Scott Nover about why these major media companies want Warner Bros., what a deal could mean for how we watch TV and movies, and how President Donald Trump could become involved in the negotiations.

Today’s show was produced by Emma Talkoff. It was edited by Ariel Plotnick and mixed by Sean Carter. Thanks to James Graff.

Subscribe to The Washington Post here.